Pharmaxis Ltd ADR (PXSLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 06-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | N/A | N/A | -9,363 | N/A |
| Depreciation Amortization | N/A | N/A | N/A | 2,173 | N/A |
| Other Working Capital | N/A | N/A | N/A | -1,053 | N/A |
| Other Operating Activity | -674 | -4,328 | 3,694 | -677 | -2,525 |
| Operating Cash Flow | $-674 | $-4,328 | $3,694 | $-8,920 | $-2,525 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -61 | -34 | -92 | -174 | -80 |
| Purchase Sale Intangibles | 1 | -17 | -113 | N/A | N/A |
| Other Investing Activity | 1 | -17 | -113 | -211 | -144 |
| Investing Cash Flow | $-60 | $-51 | $-206 | $-385 | $-224 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,088 | 6,608 | N/A | N/A | N/A |
| Other Financing Activity | -734 | -660 | -938 | -1,680 | -848 |
| Financing Cash Flow | $5,354 | $5,948 | $-938 | $-1,680 | $-848 |
| Exchange Rate Effect | 319 | N/A | N/A | 0 | N/A |
| Beginning Cash Position | 5,875 | 13,632 | 10,804 | 20,900 | 21,289 |
| End Cash Position | 10,814 | 15,201 | 13,355 | 9,914 | 17,691 |
| Net Cash Flow | $4,939 | $1,569 | $2,550 | $-10,986 | $-3,598 |
| Free Cash Flow | |||||
| Operating Cash Flow | -674 | -4,328 | 3,694 | -8,920 | -2,525 |
| Capital Expenditure | -61 | -34 | -92 | N/A | N/A |
| Free Cash Flow | -735 | -4,362 | 3,602 | -8,920 | -2,525 |